Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest hypoglycemia Stories

2012-10-05 10:22:28

DANBURY, Conn., Oct. 5, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today announced it will be hosting a meeting for analysts and investors on October 11, 2012 in New York. During the meeting, independent experts in the field of diabetes will provide an overview of the unmet medical needs and review the therapeutics in development as they relate to Biodel's major programs. Biodel's senior management will review the company's pipeline in areas of ultra-rapid-acting insulin, glucagon and...

2012-10-02 02:28:58

BERLIN, Oct. 2, 2012 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced that use of the investigational medicine canagliflozin substantially lowered blood glucose levels when used as add-on therapy in patients on insulin therapy for type 2 diabetes and who are considered to be at greater risk for cardiovascular disease. These results were presented at the 48th European Association for the Study of Diabetes (EASD) Annual Meeting. CANVAS (CANagliflozin...

2012-09-10 11:02:56

NIH-supported findings diverge from previous studies showing that blood sugar control benefits adults Tight blood sugar control in infants and children undergoing heart surgery does not lower the risk of infection or improve recovery, according to a study funded by the National Institutes of Health. Infants and children who have undergone heart surgery commonly develop high blood sugar levels, which may be associated with health issues and death. Although the results of clinical trials...

2012-09-10 10:58:02

Study drives home importance of addressing unique needs in specific patient populations Although some studies have portrayed tight blood sugar control as a potential means of lowering infection rates in critically ill adults, a new study–led by principal investigator Michael Agus, MD, director of the Medicine Critical Care Program at Boston Children's Hospital–found no indication that the approach benefits pediatric patients undergoing heart surgery. The results of the Safe...

2012-09-07 14:21:43

Boston Children's Hospital Study drives home importance of addressing unique needs in specific patient populations BOSTON, Sept. 7, 2012 /PRNewswire-USNewswire/ -- Although some studies have portrayed tight blood sugar control as a potential means of lowering infection rates in critically ill adults, a new study--led by principal investigator Michael Agus, MD, director of the Medicine Critical Care Program at Boston Children's Hospital--found no indication that the approach benefits...

2012-08-17 10:22:04

RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 17, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Tradjenta® (linagliptin) tablets for use as add-on therapy to insulin. TRADJENTA is a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes, and can be used as...

2012-08-01 10:27:18

--Children's Hospital of Philadelphia Researchers Develop First Potential Medicine for Patients with Most Severe Form of this Disease-- PHILADELPHIA, Aug.1, 2012 /PRNewswire-USNewswire/ -- A pilot study in adolescents and adults has found that an investigational drug shows promise as the first potential medical treatment for children with the severest type of congenital hyperinsulinism, a rare but potentially devastating disease in which gene mutations cause insulin levels to become...

2012-08-01 02:27:59

PHILADELPHIA, Aug. 1, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude® SkinPrep System for transdermal drug delivery, today announced positive results from its clinical trial of the Symphony tCGM System in major general surgery and cardiothoracic surgery patients. This study is the second of two studies in critically...

2012-07-30 02:26:08

INDIANAPOLIS, July 30, 2012 /PRNewswire/ -- News Highlights Lilly and ICAN begin research to probe changes in human sweat, detectable by dogs, that signals low sugar in people with T1 #diabetes Lilly supports a volunteer program where employees help reinforce the skills of assistance dogs to help people with #diabetes A young black Lab named Pete sleeps at the feet of Dr. Dana Hardin, medical director and pediatric endocrinologist, at Eli Lilly and Company (NYSE: LLY) campus...

2012-07-25 02:31:38

RIDGEFIELD, Conn. and INDIANAPOLIS, July 25, 2012 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced the receipt of Marketing Authorization from the European Commission for Jentadueto® (linagliptin/metformin hydrochloride) tablets, a medicine combining the DPP-4 inhibitor, linagliptin (the active ingredient in Tradjenta® tablets, marketed under the trade name Trajenta® in Europe) and metformin in a single tablet taken twice daily.(1 ) The...


Latest hypoglycemia Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »